[Methicillin-resistant Staphylococcus aureus disease in Panama].

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Anales de Pediatría

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.anpedi.2011.02.008PMID 21454143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Community-associated Staphylococcus aureus infections in children

  2010cited by this paper
• Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America.

  2009cited by this paper
• TRIMETHOPRIM-SULFAMETHOXAZOLE OR CLINDAMYCIN FOR TREATMENT OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS

  2009cited by this paper
• Molecular Pathogenesis of Staphylococcus aureus Infection

  2009cited by this paper
• Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals

  2008cited by this paper
• A predictive model for identifying surgical patients at risk of methicillin-resistant Staphylococcus aureus carriage on admission.

  2008cited by this paper
• The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review.

  2008cited by this paper
• Clinical Utility of Infection Control Documentation of Prior Methicillin-Resistant Staphylococcus aureus Colonization or Infection for Optimization of Empirical Antibiotic Therapy

  2008cited by this paper
• The risk of infection after nasal colonization with Staphylococcus aureus.

  2008cited by this paper
• [Community-acquired methicillin-resistant Staphylococcus aureus infections in children: multicenter trial].

  2008cited by this paper
• Characterization of Community-Acquired Staphylococcus aureus Infections in Children

  2007cited by this paper
• [Community-acquired methicillin-resistant Staphylococcus aureus in Bogotá, Colombia: Public Health implications].

  2007cited by this paper
• Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units

  2007cited by this paper
• The emergence of infections with community-associated methicillin resistant Staphylococcus aureus.

  2006cited by this paper
• Community-acquired methicillin-resistant Staphylococcus aureus infections in children.

  2006cited by this paper
• Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia

  2006cited by this paper
• Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.

  2006cited by this paper
• Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003.

  2006cited by this paper
• First Report of Infection with Community-Acquired Methicillin-Resistant Staphylococcus aureus in South America

  2005cited by this paper
• Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units

  2005cited by this paper
• Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

  2004cited by this paper
• Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

  2004cited by this paper
• Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.

  2003cited by this paper
• Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs

  2002cited by this paper
• Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

  2002cited by this paper
• Methicillin-Resistant Staphylococcus Aureus and Antimicrobial Use in Belgian Hospitals

  1999cited by this paper
• Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors.

  1999cited by this paper
• Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary.

  1999cited by this paper
• Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

  1998cited by this paper

• Serum Phosphorylated Neurofilament Heavy subunit levels and its association with the Risk for Catastrophic Injury in Thoroughbred Racehorses.

  2022cites this paper
• Características epidemiológicas de pacientes que presentan portación nasal de staphylococcus aureus meticilino resistente

  2020cites this paper
• Infective Endocarditis at Costa Rica’s Children’s Hospital, 2000–2011

  2014cites this paper
• [High-dose daptomycin use in methicillin-resistant Staphylococcus aureus disseminated infection].

  2013cites this paper
• Staphylococcus aureus resistente a meticilina (SARM) en un Hospital Pediátrico, comunidad urbana y rural

  2012cites this paper
• Molecular epidemiology and characterisation of MRSA isolates from Trinidad and Tobago

  2011cites this paper